Skip to main content
Premium Trial:

Request an Annual Quote

Waters Licenses Mass Spec Standardization Tech From SISCAPA

NEW YORK (GenomeWeb) – SISCAPA Assay Technologies (SAT) said Wednesday that it has licensed a stable isotope-labeled (SIL) standards technology to Waters.

Waters said it will use the non-exclusive license to explore the technology as a tool for standardizing quantitative mass spec assays.

The technology uses multiple SIL standards to target molecules, allowing researchers to create internal standard calibration curves for their assays. According to SAT, this could lower the time and cost of such assays.

“With the licensing of SAT’s technology, we are now in the process of evaluating the benefits of the approach for quantitative LC/MS assays in a number of application areas,” Jeff Mazzeo, Waters vice president of marketing, said in a statement.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.